Xavier Adhoute

2.4k total citations
52 papers, 1.2k citations indexed

About

Xavier Adhoute is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xavier Adhoute has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 27 papers in Epidemiology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xavier Adhoute's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (22 papers) and Hepatitis B Virus Studies (14 papers). Xavier Adhoute is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease Diagnosis and Treatment (22 papers) and Hepatitis B Virus Studies (14 papers). Xavier Adhoute collaborates with scholars based in France, United States and Switzerland. Xavier Adhoute's co-authors include Patrice Couzigou, Juliette Foucher, David Laharie, J. Bertet, Marc Bourlière, Paul Castellani, Pierre–Henri Bernard, Jean‐Luc Raoul, Valérie Oulès and Guillaume Pénaranda and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Xavier Adhoute

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xavier Adhoute France	17	784	748	199	188	127	52	1.2k
Shintaro Takaki Japan	20	954 1.2×	601 0.8×	352 1.8×	156 0.8×	131 1.0×	77	1.2k
Takahide Nakazawa Japan	20	1.1k 1.4×	691 0.9×	327 1.6×	157 0.8×	150 1.2×	60	1.4k
Anna Pecorelli Italy	14	664 0.8×	668 0.9×	159 0.8×	143 0.8×	110 0.9×	44	1.1k
Young‐Joo Jin South Korea	20	744 0.9×	621 0.8×	288 1.4×	159 0.8×	146 1.1×	78	1.1k
G.G. Di Costanzo Italy	19	958 1.2×	700 0.9×	188 0.9×	164 0.9×	165 1.3×	71	1.3k
Kouji Joko Japan	16	729 0.9×	533 0.7×	149 0.7×	165 0.9×	99 0.8×	59	903
Kwong‐Ming Kee Taiwan	25	1.3k 1.6×	1.1k 1.4×	251 1.3×	188 1.0×	127 1.0×	87	1.6k
Miho Nakao Japan	8	765 1.0×	729 1.0×	236 1.2×	308 1.6×	67 0.5×	17	1.2k
Yi‐Hao Yen Taiwan	23	1.3k 1.6×	1.1k 1.5×	207 1.0×	147 0.8×	100 0.8×	126	1.6k
Chikara Ogawa Japan	15	872 1.1×	431 0.6×	205 1.0×	164 0.9×	176 1.4×	50	1.2k

Countries citing papers authored by Xavier Adhoute

Since Specialization

Citations

This map shows the geographic impact of Xavier Adhoute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Adhoute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Adhoute more than expected).

Fields of papers citing papers by Xavier Adhoute

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Adhoute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Adhoute. The network helps show where Xavier Adhoute may publish in the future.

Co-authorship network of co-authors of Xavier Adhoute

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Adhoute. A scholar is included among the top collaborators of Xavier Adhoute based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Adhoute. Xavier Adhoute is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pénaranda, Guillaume, Sylvie Deuffic‐Burban, Laurence Lecomte, et al.. (2025). Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO Study. Journal of Viral Hepatitis. 32(6). e70038–e70038.

Allaire, Manon, Julien Edeline, P. Merle, et al.. (2025). 1487P Extended follow-up at 42 months of atezolizumab–bevacizumab in advanced HCC: Insights from the CHIEF prospective study. Annals of Oncology. 36. S829–S829.

Gao, Wenfeng, et al.. (2025). Efficacy and safety of transcatheter arterial embolization combined with ablation and regorafenib for unresectable hepatocellular carcinoma patients failing first-line treatment: a real-world study. Journal of Gastrointestinal Oncology. 16(3). 1050–1059.

Merle, Philippe, Jean-Marie Péron, Karine Le Malicot, et al.. (2024). Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 42(16_suppl). e16195–e16195. 1 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Thomas Wolf, et al.. (2023). Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations

Neuzillet, Cindy, Pascal Artru, Eric Assénat, et al.. (2023). Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective. Targeted Oncology. 18(1). 51–76. 9 indexed citations

Adhoute, Xavier, Laurent Mineur, Guillaume Pénaranda, et al.. (2022). Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching. World Journal of Gastrointestinal Oncology. 14(8). 1510–1527. 7 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2020). “Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort. World Journal of Hepatology. 12(8). 525–532. 2 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2019). Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort. European Journal of Gastroenterology & Hepatology. 31(11). 1414–1423. 3 indexed citations

10.

Raoul, Jean‐Luc, Judith Raimbourg, Sandrine Hiret, Xavier Adhoute, & Hélène Senellart. (2018). Épidémiologie du carcinome hépatocellulaire : simple augmentation d’incidence ou futur drame ?. Bulletin du Cancer. 105(5). 502–507. 2 indexed citations

11.

Raoul, Jean‐Luc, Xavier Adhoute, Marine Gilabert, & Julien Edeline. (2016). How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma. World Journal of Hepatology. 8(35). 1541–1541. 10 indexed citations

12.

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2015). Prognosis of advanced hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. 28(4). 433–440. 27 indexed citations

13.

Adhoute, Xavier, Guillaume Pénaranda, J.F. Blanc, et al.. (2015). P0376 : Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study. Journal of Hepatology. 62. S453–S453. 1 indexed citations

14.

Edeline, Julien, Laurence Crouzet, Boris Campillo‐Gimenez, et al.. (2015). Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. European Journal of Nuclear Medicine and Molecular Imaging. 43(4). 635–643. 67 indexed citations

15.

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology. 62(4). 855–862. 117 indexed citations

16.

Bourlière, Marc, et al.. (2014). Sofosbuvir as backbone of interferon free treatments. Digestive and Liver Disease. 46. S212–S220. 20 indexed citations

17.

Bourlière, Marc, Claire Wartelle‐Bladou, Valérie Oulès, et al.. (2011). Chronic hepatitis C: Treatments of the future. Clinics and Research in Hepatology and Gastroenterology. 35. S84–S95. 19 indexed citations

18.

Smith, D. M., R. Brunet, Xavier Adhoute, et al.. (2006). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in second and third-line treatment of metastatic colorectal cancer (mCRC): Safety and efficacy analysis. Journal of Clinical Oncology. 24(18_suppl). 3558–3558. 3 indexed citations

19.

Foucher, Juliette, Pierre–Henri Bernard, Xavier Adhoute, et al.. (2006). Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. European Journal of Gastroenterology & Hepatology. 18(4). 411–412. 309 indexed citations

20.

Cunha, António Sá, A. Rault, Alexis Laurent, et al.. (2005). Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas. Journal of the American College of Surgeons. 201(3). 359–365. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact